Blog

Thomas LeBlanc: I signed ASCO’s letter to end the drug shortage crisis

Photo from Thomas LeBlanc/X

Feb 29, 2024, 05:15

Thomas LeBlanc: I signed ASCO’s letter to end the drug shortage crisis

Thomas LeBlanc, Chief Patient Experience and Safety Officer for the Duke Cancer Institute, shared on X/Twitter:

“I signed ASCO’s letter from America’s cancer doctors and providers urging policymakers to end the drug shortage crisis. Patients are still struggling to get the treatments they need.

Add your voice to the push for solutions and sign the letter!”

Further details.
Source: Thomas LeBlanc/X

ASCO ASCO Advocacy cancer cancer treatment drug shortage Duke Cancer Institute medical advocacy OncoDaily Oncology policy change public health Thomas LeBlanc

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity